“As the world works towards an effective COVID-19 vaccine, we cannot lose sight of the importance of developing treatments to prevent a worsening of the disease for those stricken with the virus. Today’s announcement is part of our Government’s plan to invest in projects that will support Canada in the global race to find treatments for COVID-19 while building domestic capabilities to fight future pandemics to protect the health and safety of all Canadians.”

- The Hon. Navdeep Bains, Minister of Innovation, Science and Industry

“Through these strategic investments, we are ensuring we support Canadian industry in developing Canada’s capacity to produce therapeutics to respond to the current COVID-19 pandemic, and for future pandemics. These therapeutic candidates will provide safe and effective treatments for those diagnosed with COVID-19.”

- Roger Scott-Douglas, PhD, Acting President, National Research Council of Canada

https://www.canada.ca/en/national-research-council/news/2020/12/national-research-council-of-canada-supports-development-of-4-covid-19-therapeutic-candidates.html

___________________

https://ised-isde.canada.ca/site/biomanufacturing/en/biomanufacturing-projects-underway

• Up to $4,609,000.00 to JN Nova Pharma (Montreal, Que) to assist in the development of a proprietary drug to block coronavirus infection, while reducing the impacts of the disease in patients exhibiting COVID-19 symptoms so they may recover faster.
• Up to $4,166,796.00 to Laurent Pharmaceuticals (Montreal, Que) for the clinical development of their LAU-7b antiviral and inflammation controlling therapy for COVID-19 infections.
  
  
  Free money!   Why do I get the feeling they have never heard from Resverlogix?